Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Pharmalink (Sweden) a clinical-stage specialty pharmaceutical company focused on IgA nephritis, and conditioning prior to hematopoietic stem cell transplantation, closed a $5.3M Series C financing. Participants include Industrifonden.

APT Pharmaceuticals (Burlingame, CA) specialty drug development company focused focused on repurposing well-characterized drugs for serious lung diseases, closed a $32.3M Series B financing. Participants include Three Arch Partners, InterWest Partners, Pinnacle Ventures, Charter Life Sciences, Great Point Partners, Versant Ventures and Vivo Ventures.

Tolera Therapeutics (Cleveland, OH) focused on immunotherapeutics for transplantation, oncology and autoimmune disease, closed an $8M Series A financing. Participants include Triathlon Medical Ventures, Southwest Michigan First Life Science Fund and Hopen Therapeutics.


to top of page...